Atle Fund Management AB as of June 30, 2025
Portfolio Holdings for Atle Fund Management AB
Atle Fund Management AB holds 37 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Eli Lilly & Co. (LLY) | 12.9 | $30M | 39k | 779.53 | |
| Abbvie (ABBV) | 6.9 | $16M | 87k | 185.62 | |
| Boston Scientific Corporation (BSX) | 5.8 | $14M | 126k | 107.41 | |
| Neurocrine Biosciences (NBIX) | 4.8 | $11M | 88k | 125.69 | |
| Merck & Co (MRK) | 4.7 | $11M | 139k | 79.16 | |
| Stryker Corporation (SYK) | 4.7 | $11M | 28k | 395.63 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 4.6 | $11M | 24k | 445.20 | |
| Intuitive Surgical Com New (ISRG) | 4.3 | $10M | 19k | 543.41 | |
| Thermo Fisher Scientific (TMO) | 4.2 | $9.8M | 24k | 405.46 | |
| AmerisourceBergen (COR) | 4.0 | $9.4M | 32k | 299.85 | |
| Gilead Sciences (GILD) | 3.5 | $8.1M | 73k | 110.87 | |
| Bridgebio Pharma (BBIO) | 3.1 | $7.1M | 166k | 43.18 | |
| Amgen (AMGN) | 2.9 | $6.7M | 24k | 279.21 | |
| Alkermes SHS (ALKS) | 2.8 | $6.5M | 227k | 28.61 | |
| BeiGene Sponsored Ads (ONC) | 2.5 | $5.9M | 24k | 242.07 | |
| Mirum Pharmaceuticals (MIRM) | 2.3 | $5.4M | 107k | 50.89 | |
| UFP Technologies (UFPT) | 2.3 | $5.3M | 22k | 244.16 | |
| Cardinal Health (CAH) | 1.9 | $4.5M | 27k | 168.00 | |
| Edwards Lifesciences (EW) | 1.9 | $4.5M | 57k | 78.21 | |
| Verona Pharma Plc - Sponsored Ads (VRNA) | 1.9 | $4.5M | 47k | 94.58 | |
| Dexcom Com New (DXCM) | 1.9 | $4.4M | 51k | 87.29 | |
| Irhythm Technologies (IRTC) | 1.7 | $3.9M | 25k | 153.96 | |
| Soleno Therapeutics (SLNO) | 1.5 | $3.4M | 41k | 83.78 | |
| Merus N V (MRUS) | 1.3 | $3.2M | 60k | 52.60 | |
| Revolution Medicines (RVMD) | 1.3 | $3.0M | 82k | 36.79 | |
| NewAmsterdam Pharma Co NV Ordinary Shares (NAMS) | 1.2 | $2.8M | 157k | 18.11 | |
| Krystal Biotech (KRYS) | 1.2 | $2.8M | 20k | 137.46 | |
| Harmony Biosciences Hldgs In (HRMY) | 1.2 | $2.7M | 86k | 31.60 | |
| Autolus Therapeutics Spon Ads (AUTL) | 1.1 | $2.5M | 1.1M | 2.28 | |
| UnitedHealth (UNH) | 1.1 | $2.5M | 14k | 181.15 | |
| Mereo Biopharma Group Spon Ads (MREO) | 0.9 | $2.1M | 765k | 2.71 | |
| Summit Therapeutics (SMMT) | 0.8 | $2.0M | 93k | 21.28 | |
| Arcellx Common Stock (ACLX) | 0.7 | $1.7M | 26k | 65.85 | |
| Bicara Therapeutics (BCAX) | 0.6 | $1.4M | 147k | 9.29 | |
| Disc Medicine (IRON) | 0.6 | $1.3M | 25k | 52.96 | |
| Corbus Pharmaceuticals Hldgs (CRBP) | 0.5 | $1.2M | 176k | 6.90 | |
| Janux Therapeutics (JANX) | 0.5 | $1.2M | 50k | 23.10 |
